Tyme Technologies Soars on Patent Claim Approval thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.
– Comprehensive strategic review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas– Recently appointed acting Chief Medical Officer and incoming Chief Financial Officer bolster leadership team expertise– Well-c.
Tyme Technologies (TYME) Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports FY21 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.